Aspen Aerogels (NYSE:ASPN) Price Target Raised to $25.00

Aspen Aerogels (NYSE:ASPN) had its target price boosted by HC Wainwright from $20.00 to $25.00 in a report released on Friday, Benzinga reports. HC Wainwright currently has a buy rating on the construction company’s stock.

ASPN has been the subject of several other research reports. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a research report on Wednesday, March 6th. Roth Mkm reaffirmed a buy rating and issued a $22.00 target price on shares of Aspen Aerogels in a report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus price target of $25.17.

Aspen Aerogels Price Performance

ASPN opened at $25.90 on Friday. The stock’s 50-day moving average price is $16.90 and its 200 day moving average price is $13.90. Aspen Aerogels has a 12-month low of $5.32 and a 12-month high of $25.91. The firm has a market cap of $1.97 billion, a price-to-earnings ratio of -58.86 and a beta of 1.97. The company has a current ratio of 4.01, a quick ratio of 3.29 and a debt-to-equity ratio of 0.24.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. During the same quarter in the previous year, the business posted ($0.20) EPS. As a group, sell-side analysts expect that Aspen Aerogels will post 0.03 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Federated Hermes Inc. boosted its stake in Aspen Aerogels by 53.9% during the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after purchasing an additional 404,042 shares during the period. Rice Hall James & Associates LLC raised its holdings in shares of Aspen Aerogels by 385.0% during the third quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock valued at $5,359,000 after buying an additional 494,662 shares during the last quarter. Sargent Investment Group LLC boosted its position in shares of Aspen Aerogels by 24.1% during the fourth quarter. Sargent Investment Group LLC now owns 337,281 shares of the construction company’s stock worth $5,322,000 after buying an additional 65,571 shares during the period. Vanguard Group Inc. grew its holdings in Aspen Aerogels by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock worth $29,635,000 after buying an additional 14,013 shares in the last quarter. Finally, Principal Financial Group Inc. acquired a new stake in Aspen Aerogels in the 3rd quarter valued at approximately $449,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.